Q2 2024 Holdings
Filed 2024-08-14 | 35 holdings | $1.5B | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Merus N V | COM | N5749R100 | $189.3M | 3,200,000 | 12.9% |
| Nuvalent Inc(NUVL) | COM | 670703107 | $112.9M | 1,487,756 | 7.7% |
| Xenon Pharmaceuticals Inc(XENE) | COM | 98420N105 | $107.4M | 2,754,266 | 7.3% |
| Vaxcyte Inc(PCVX) | COM | 92243G108 | $98.5M | 1,305,000 | 6.7% |
| Enliven Therapeutics Inc(ELVN) | COM | 29337E102 | $92.9M | 3,973,245 | 6.3% |
| Vera Therapeutics Inc(VERA) | CL A | 92337R101 | $89.5M | 2,475,000 | 6.1% |
| Cogent Biosciences Inc(COGT) | COM | 19240Q201 | $82.1M | 9,738,000 | 5.6% |
| Soleno Therapeutics Inc(SLNO) | COM | 834203309 | $58.1M | 1,425,000 | 4.0% |
| Celldex Therapeutics Inc New(CLDX) | COM NEW | 15117B202 | $52.7M | 1,425,000 | 3.6% |
| Mind Medicine Mindmed Inc(BRD1EUR) | COM NEW | 60255C885 | $51.5M | 7,145,888 | 3.5% |
| Rhythm Pharmaceuticals Inc(RYTM) | COM | 76243J105 | $50.3M | 1,225,000 | 3.4% |
| Arvinas Inc(ARVN) | COM | 04335A105 | $50.2M | 1,884,361 | 3.4% |
| Spyre Therapeutics Inc(SYRE) | COM NEW | 00773J202 | $46.7M | 1,988,084 | 3.2% |
| Perspective Therapeutics Inc(CATX) | COM NEW | 46489V302 | $46.4M | 4,657,345 | 3.2% |
| Pharvaris N V(PHVS) | COM | N69605108 | $34.0M | 1,810,175 | 2.3% |
| Alkermes PLC(ALKS) | SHS | G01767105 | $33.1M | 1,375,000 | 2.3% |
| Viridian Therapeutics Inc(VRDN) | COM | 92790C104 | $32.9M | 2,528,032 | 2.2% |
| Kura Oncology Inc(KURA) | COM | 50127T109 | $32.8M | 1,593,350 | 2.2% |
| Nkarta Inc(NKTX) | COM | 65487U108 | $24.5M | 4,151,034 | 1.7% |
| Celcuity Inc(CELC) | COM | 15102K100 | $24.0M | 1,464,105 | 1.6% |
| Third Harmonic BIO Inc(THRD) | COM | 88427A107 | $20.1M | 1,545,426 | 1.4% |
| Immunovant Inc(IMVT) | COM | 45258J102 | $19.8M | 750,990 | 1.4% |
| Abivax SA(ABVX) | SPONSORED ADS | 00370M103 | $17.0M | 1,284,110 | 1.2% |
| Syndax Pharmaceuticals Inc(SNDX) | COM | 87164F105 | $16.9M | 825,000 | 1.2% |
| C4 Therapeutics Inc(CCCC) | COM STK | 12529R107 | $15.8M | 3,410,384 | 1.1% |
| Oric Pharmaceuticals Inc(ORIC) | COM | 68622P109 | $14.1M | 2,000,000 | 1.0% |
| Apogee Therapeutics Inc(APGE) | COM | 03770N101 | $11.4M | 290,000 | 0.8% |
| Cabaletta BIO Inc(CABA) | COM | 12674W109 | $8.2M | 1,100,000 | 0.6% |
| Perceptive Cap Solutions COR | CL A ORD SHS | G70077105 | $7.5M | 750,000 | 0.5% |
| Neurogene Inc(NGNE) | COM | 64135M105 | $7.3M | 200,000 | 0.5% |
| Vistagen Therapeutics Inc(VTGN) | COM | 92840H400 | $5.5M | 1,575,000 | 0.4% |
| Helix Acquisition Corp II | CL A ORD SHS | G4444H101 | $5.1M | 500,000 | 0.3% |
| Autolus Therapeutics PLC(AUTL) | SPON ADS | 05280R100 | $4.1M | 1,178,723 | 0.3% |
| Arca Biopharma Inc(ABIOEUR) | COM | 00211Y506 | $1.6M | 414,325 | 0.1% |
| Avalo Therapeutics Inc(AVTX) | COM NEW | 05338F306 | $498.8K | 40,000 | 0.0% |